Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Ischemia Reperfusion Injury · Delayed Graft Function

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Rhode Island Hospital, Providence, Rhode Island, United States
Contact: Study coordinator (George Bayliss, MD) · gbayliss@Lifespan.org · 401-444-8562
Contact: Study coordinator (Nisanne Ghonem, PharmD, PhD) · nghonem@uri.edu · 401-874-4805

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction

Myocardial Infarction · Reperfusion Injury · AMI

Abroad (travel likely)RecruitingPHASE2

Kingswood, Australia · Liverpool, Australia

A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)

Ischemia Reperfusion Injury · Cardiac Surgery Associated - Acute Kidney Injury

Abroad (travel likely)RecruitingPHASE2

Daegu, South Korea · Seongnam, South Korea

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial

Ischemia Reperfusion Injury · Myocardial Injury · Acute Kidney Injury

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States

Hypertonic Lactate After Cardiac Arrest

Cardiac Arrest · Ischemia Reperfusion Injury · Anoxic Brain Injury

Abroad (travel likely)RecruitingPHASE2

Brussels, Belgium